Free Trial

Life Science REIT (LABS) Competitors

Life Science REIT logo
GBX 35.70 +0.90 (+2.59%)
As of 02/21/2025 11:55 AM Eastern

LABS vs. IHR, MXF, AGR, PHP, THRL, RDI, LOK, PCTN, WHR, and NRR

Should you be buying Life Science REIT stock or one of its competitors? The main competitors of Life Science REIT include Impact Healthcare REIT (IHR), Medicx Fund (MXF), Assura (AGR), Primary Health Properties (PHP), Target Healthcare REIT (THRL), Rdi Reit (RDI), Lok'nStore Group (LOK), Picton Property Income (PCTN), Warehouse REIT (WHR), and NewRiver REIT (NRR). These companies are all part of the "real estate" sector.

Life Science REIT vs.

Impact Healthcare REIT (LON:IHR) and Life Science REIT (LON:LABS) are both small-cap real estate companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, community ranking, institutional ownership and dividends.

Impact Healthcare REIT has higher revenue and earnings than Life Science REIT. Life Science REIT is trading at a lower price-to-earnings ratio than Impact Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Impact Healthcare REIT£53.51M0.00£47.58M£0.11N/A
Life Science REIT£20.41M6.21-£40.62M-£11.28-3.17

Impact Healthcare REIT pays an annual dividend of GBX 7 per share. Life Science REIT pays an annual dividend of GBX 2 per share and has a dividend yield of 5.6%. Impact Healthcare REIT pays out 6,363.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Life Science REIT pays out -17.7% of its earnings in the form of a dividend. Life Science REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.

Impact Healthcare REIT has a net margin of 88.90% compared to Life Science REIT's net margin of -198.99%. Impact Healthcare REIT's return on equity of 9.90% beat Life Science REIT's return on equity.

Company Net Margins Return on Equity Return on Assets
Impact Healthcare REIT88.90% 9.90% 4.30%
Life Science REIT -198.99%-14.53%1.25%

Impact Healthcare REIT has a beta of 0.37, meaning that its share price is 63% less volatile than the S&P 500. Comparatively, Life Science REIT has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500.

In the previous week, Impact Healthcare REIT and Impact Healthcare REIT both had 1 articles in the media. Impact Healthcare REIT's average media sentiment score of 1.02 beat Life Science REIT's score of 0.00 indicating that Impact Healthcare REIT is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Impact Healthcare REIT
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Life Science REIT
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Impact Healthcare REIT presently has a consensus target price of GBX 114, suggesting a potential upside of 0.00%. Life Science REIT has a consensus target price of GBX 46.50, suggesting a potential upside of 30.25%. Given Life Science REIT's higher possible upside, analysts clearly believe Life Science REIT is more favorable than Impact Healthcare REIT.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Impact Healthcare REIT
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Life Science REIT
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Impact Healthcare REIT received 42 more outperform votes than Life Science REIT when rated by MarketBeat users. However, 80.00% of users gave Life Science REIT an outperform vote while only 77.97% of users gave Impact Healthcare REIT an outperform vote.

CompanyUnderperformOutperform
Impact Healthcare REITOutperform Votes
46
77.97%
Underperform Votes
13
22.03%
Life Science REITOutperform Votes
4
80.00%
Underperform Votes
1
20.00%

59.5% of Impact Healthcare REIT shares are owned by institutional investors. Comparatively, 67.3% of Life Science REIT shares are owned by institutional investors. 9.3% of Impact Healthcare REIT shares are owned by insiders. Comparatively, 7.0% of Life Science REIT shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Impact Healthcare REIT beats Life Science REIT on 12 of the 18 factors compared between the two stocks.

Get Life Science REIT News Delivered to You Automatically

Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LABS vs. The Competition

MetricLife Science REITREIT IndustryReal Estate SectorLON Exchange
Market Cap£126.75M£1.52B£1.53B£2.63B
Dividend Yield5.67%7.52%6.66%4.98%
P/E Ratio-3.171.199.69163.28
Price / Sales6.21474.171,439.57312,084.15
Price / CashN/A49.2266.9728.02
Price / Book0.471.311.245.14
Net Income-£40.62M-£74.43M-£120.05M£5.73B
7 Day Performance4.08%4.55%-0.38%-0.99%
1 Month Performance8.18%6.32%1.42%-0.81%
1 Year Performance-24.04%3.78%2.94%39.26%

Life Science REIT Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LABS
Life Science REIT
1.9259 of 5 stars
GBX 35.70
+2.6%
GBX 46.50
+30.3%
-24.0%£126.75M£20.41M-3.17N/ANews Coverage
Gap Down
IHR
Impact Healthcare REIT
2.3446 of 5 stars
N/AGBX 114
+∞
N/A£361.75M£53.51M793.64N/A
MXF
Medicx Fund
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
AGR
Assura
2.3209 of 5 stars
GBX 43.48
+2.3%
GBX 49.50
+13.8%
+4.8%£1.42B£188.76M-41.5684News Coverage
High Trading Volume
PHP
Primary Health Properties
1.2529 of 5 stars
GBX 94.05
-1.4%
GBX 107.50
+14.3%
+2.3%£1.26B£178.59M-146.8158
THRL
Target Healthcare REIT
N/AGBX 85.40
-0.6%
N/A+7.6%£522.74M£68.64M7.16N/ANews Coverage
RDI
Rdi Reit
N/AN/AN/AN/A£462.34M£68.40M-4.442,020
LOK
Lok'nStore Group
N/AN/AN/AN/A£356.58M£27.73M8,500.00193
PCTN
Picton Property Income
N/AGBX 65.60
+0.2%
N/A+2.6%£355.25M£54.17M44.0310News Coverage
Gap Up
WHR
Warehouse REIT
3.4933 of 5 stars
GBX 83.50
-0.6%
GBX 108
+29.3%
+1.7%£353.72M£50.81M0.8161,000
NRR
NewRiver REIT
N/AGBX 72.80
-0.4%
N/A-7.0%£347.31M£110.63M75.8146

Related Companies and Tools


This page (LON:LABS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners